Optimizing Use of ADT Backbone Therapy Across Subsets of Prostate Cancer
EP. 1: Cardiovascular Disease Risk in Men with Prostate Cancer
Expert perspectives on the risk of cardiovascular disease as it exists in the context of androgen deprivation therapy (ADT) and prostate cancer.
EP. 2: Examining the Data From Key Clinical Trials, and Practical Strategies
Shared insight on a timeline of clinical studies contextualizing cardiovascular disease in the setting of prostate cancer management.
EP. 3: Strategies for Mitigating Cardiovascular Risk
Comprehensive insight regarding strategies to mitigate cardiovascular risk in patients on therapy for prostate cancer.
EP. 4: Summary and Case Study
Centering focus on a patient case of cardiovascular risk and prostate cancer, experts share their perspective on management strategies.
EP. 5: A Medical Oncologist Reflects on a Typical Prostate Cancer Patient
Oncologist Joelle Hamilton, MD, shares her perspective on the typical patient with prostate cancer seen at her institution.
EP. 6: A Urologist Reflects on a Typical Prostate Cancer Patient
Urologist David Morris, MD, FACS, defines the typical patient with prostate cancer treated at his practice.
EP. 7: A Cardiologist Reflects on a Typical Prostate Cancer Patient
Cardiologist Anees A. Daud, MD, breaks down the typical patient with prostate cancer seen at his practice.
EP. 8: Practice-Related And Provider-Patient Communication Strategies For Prostate Cancer Care
Expert perspectives on strategies to optimize communication, both between healthcare professionals and with patients who present with prostate cancer.
EP. 9: A Cardiologist’s Perspective on Cardiovascular Risk Assessment in Prostate Cancer
Direct insight from a cardiologist on the advent of cardiovascular risk when treating a patient for prostate cancer.
EP. 10: A Medical Oncologist’s Perspective on Cardiovascular Risk Assessment in Prostate Cancer
Medical oncologist Joelle Hamilton, MD, reflects on the prevalence of cardiovascular risk while managing prostate cancer in patients.
EP. 11: Typical Examinations And Tests For Cardiovascular Risk Assessment in a Cardiology Practice
Cardiologist Anees A. Daud, MD, elucidates examinations and tests that help to identify cardiovascular risk in practice.
EP. 12: Typical Examinations And Tests For Cardiovascular Risk Assessment in an Oncology Practice
Expert perspectives on the typical patient workup that occurs in oncology practice to identify cardiovascular risk.
EP. 13: A Cardiologist’s Recommended Interventions For Cardiovascular Risk Mitigation
Insight is provided on strategies that may be employed to mitigate cardiovascular risk in patients receiving care for prostate cancer.
EP. 14: A Medical Oncologist’s Recommended Interventions For CV Risk Mitigation
Joelle Hamilton, MD, reflects on strategies used in oncology practice to mitigate cardiovascular risk in patients with prostate cancer.
EP. 15: Strategies For Communicating Cardiovascular Risk to Patients Starting on ADT
Urologist David Morris, MD, FACS, shares his perspective on communicating cardiovascular risk to patients starting androgen deprivation therapy.
EP. 16: Considerations For ADT Selection And Patient Education on Treatment-Related AEs
Expert insight on selection of androgen deprivation therapy and how related adverse events may be communicated to patients in advance.
EP. 17: A Urologist’s Approach to Followup For Patients on ADT And Practice Communication Strategies
David Morris, MD, FACS, shares advice on followup with patients on androgen deprivation therapy for prostate cancer.
EP. 18: A Cardiologist’s Approach to Followup For Patients on ADT and Strategies in Multidisciplinary Care
Cardiologist Anees A. Daud, MD, highlights how a cardiologist may followup with patients receiving androgen deprivation therapy and how multidisciplinary care plays a role in this setting.
EP. 19: A Urologist Reacts to AbbVie’s Educational Video: Key Takeaways And Clinical Impact
Insight from Urologist David Morris, MD, FACS, as he reacts to the educational video from AbbVie on cardiovascular risk and androgen deprivation therapy.
EP. 20: A Cardiologist Reacts to AbbVie’s Educational Video: Key Takeaways And Clinical Impact
Insight from cardiologist Anees A. Daud, MD, following his viewing of AbbVie’s educational video on cardiovascular risk and androgen deprivation therapy.